CHEM2052 Tutorial Example4
From Proteopedia
(Difference between revisions)
| Line 23: | Line 23: | ||
This inhibitor does not just bind to the catalytic residues there are many other amino acids at the active site of the enzyme. First predict possible interaction types you would expect with this structure. Then look at the 2-dimensional "map" of the active site provided on your tutorial sheet and compare this to the 3-dimensional representations here. | This inhibitor does not just bind to the catalytic residues there are many other amino acids at the active site of the enzyme. First predict possible interaction types you would expect with this structure. Then look at the 2-dimensional "map" of the active site provided on your tutorial sheet and compare this to the 3-dimensional representations here. | ||
| - | This view shows the amino acid residues on the left hand side of your "map". You may notice that these amino acids are fairly hydrophobic and interact with the hydrophobic parts of the inhibitor. | + | This view shows the amino acid residues on the <scene name='59/596437/Renin_interactions_rhs/1'>left hand side</scene> of your "map". You may notice that these amino acids are fairly hydrophobic and interact with the hydrophobic parts of the inhibitor. |
Similarly this view shows the amino acid residues on the right hand side of your "map". | Similarly this view shows the amino acid residues on the right hand side of your "map". | ||
Revision as of 08:27, 13 August 2014
CHEM2052_Tutorial_Example4
| |||||||||||
References
- ↑ Powell NA, Ciske FL, Cai C, Holsworth DD, Mennen K, Van Huis CA, Jalaie M, Day J, Mastronardi M, McConnell P, Mochalkin I, Zhang E, Ryan MJ, Bryant J, Collard W, Ferreira S, Gu C, Collins R, Edmunds JJ. Rational design of 6-(2,4-diaminopyrimidinyl)-1,4-benzoxazin-3-ones as small molecule renin inhibitors. Bioorg Med Chem. 2007 Sep 1;15(17):5912-49. Epub 2007 Jun 2. PMID:17574423 doi:10.1016/j.bmc.2007.05.069

